Shaping the Future of Microbial Development: From Gene to GMP

Accelerate your path from early development to GMP with proven strategies that de-risk scale-up and boost speed and scalability in microbial bioprocessing. Discover how to streamline the development of your complex biologic into robust, commercially viable processes.

Register Free: https://www.pharmtech.com/pt_w/shaping-the-future

Event Overview:

Speed and scalability now define success in microbial bioprocessing. Join us to explore proven approaches that shorten development timelines and reduce scale-up risk—from early development through GMP. See how platforms like PavewayPLUS™ and ShunzymeX™ streamline development and how FUJIFILM Biotechnologies’ 30-plus years of experience in expressing, purifying, and formulating soluble and insoluble biologics with and without conjugation/PEGylation enables rapid, confident progression to GMP with robust, scalable, and commercially viable processes.

Key Learning Objectives:

In this webinar, you will learn:

1. Practical methods to accelerate the journey from gene to GMP without compromising quality
2. Strategies to navigate common challenges in PEGylated and conjugated therapy development
3. How FUJIFILM Biotechnologies can help you formulate and perform drug product clinical mimic studies, so you understand the shelf life and stressors of DP filling on your therapy

Who should Attend:

• Large and small biotech, spin-outs, and academics
• Anyone with CMC or procurement in their titles
• Technical directors and above
• CSOs
• Heads of science and above
• Consultants
  

Speaker:

Steve Loftus, PhD
Director, Commercial Technical Lead for Biologics
FUJIFILM Biotechnologies

Steve Loftus, PhD, serves as director, commercial technical lead for biologics at FUJIFILM Biotechnologies. With over 19 years in the biotechnology industry, he excels in strategic growth and project management, focusing on mammalian cell culture and microbial service offerings. Loftus plays a pivotal role in solution-based selling, aligning technical offerings with client needs, and guiding FUJIFILM Biotechnologies to industry leadership. Loftus holds a PhD in biochemistry/biophysics from the University of York and a degree in medical microbiology from the University of Newcastle.

Register Free: https://www.pharmtech.com/pt_w/shaping-the-future